BLOOD ANALYSIS LIMITED

34 HIGH STREET, ALDRIDGE, WALSALL  WS9 8LZ
  • Active - Proposal to Strike off
  • Private Limited Company
  • Company No. 04426672
  • Last Updated: 01 Mar 2024

Company Profile

BLOOD ANALYSIS LIMITED was incorporated on Monday, April 29, 2002 as a Private Limited Company with registered address in WALSALL. BLOOD ANALYSIS LIMITED has the status: Active - Proposal to Strike off and it's listed in the following category: Other research and experimental development on natural sciences and engineering. This Private Limited Company has been operating for 22 years 6 months and 10 days.

Name BLOOD ANALYSIS LIMITED
Company number 04426672
Company type Private Limited Company
Incorporation date 29 Apr 2002
Status Active - Proposal to Strike off
Industry (SIC 2007)

Address

Registered Address 34 HIGH STREET
ALDRIDGE
WALSALL
WS9 8LZ
Country Of Origin ENGLAND

Map based on PostCode

Ownership Information

Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.

Name Nature of Control
Mr Peter Salmon Nationality: British Dates: Thursday, May 5, 2016 - Friday, March 9, 2018
significant influence or control
Bioco Lumted 34 High St, Aldridge, WS9 8LZ Dates: Wednesday, April 6, 2016 - present
ownership of shares 75 to 100 percent
voting rights 75 to 100 percent
right to appoint and remove directors
Bioco Limited High Street, Aldridge, WS9 8LZ Dates: Wednesday, April 6, 2016 - present
ownership of shares 75 to 100 percent
voting rights 75 to 100 percent

Accounts and Confirmation

Type of accounts TOTAL EXEMPTION FULL
End of financial Year 30 April
Next annual accounts due 31 January 2020, (-1744 days left)
Latest accounts 30 April 2018
Next confirmation statement due 27 May 2017
Last confirmation statement dated 29 April 2016

Mortgages

Total of Mortgages 4
Mortgages Outstanding 4
Mortgages Partially Satisfied 0
Mortgages Satisfied/Paid 0

Previous Names

Name Change Date
BLOOD ANALYSIS LIMITED 29 Apr 2002